Inspira Technologies OXY B.H.N. (NASDAQ:IINN) Shares Down 5.3% – Should You Sell?

Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN)’s share price traded down 5.3% on Thursday . The stock traded as low as $1.39 and last traded at $1.42. Approximately 1,702,811 shares were traded during mid-day trading, an increase of 383% from the average daily volume of 352,435 shares. The stock had previously closed at $1.50.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Inspira Technologies OXY B.H.N. in a research report on Friday, April 10th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Inspira Technologies OXY B.H.N. currently has an average rating of “Sell”.

Inspira Technologies OXY B.H.N. Stock Down 5.3%

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.30 and a current ratio of 1.56. The stock’s fifty day moving average price is $1.45 and its two-hundred day moving average price is $0.92.

Institutional Investors Weigh In On Inspira Technologies OXY B.H.N.

Several institutional investors and hedge funds have recently bought and sold shares of the business. Kestra Advisory Services LLC purchased a new stake in Inspira Technologies OXY B.H.N. in the 4th quarter worth approximately $71,000. Citadel Advisors LLC purchased a new position in shares of Inspira Technologies OXY B.H.N. during the third quarter valued at approximately $105,000. Finally, Yorkville Advisors Global LP bought a new position in shares of Inspira Technologies OXY B.H.N. during the fourth quarter valued at approximately $1,605,000. Hedge funds and other institutional investors own 12.72% of the company’s stock.

About Inspira Technologies OXY B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.